Coronapod: COVID boosters amidst global vaccine inequity

Coronapod: COVID boosters amidst global vacci...

Up next

Briefing Chat: Orcas smashed a sunfish to bits — researchers aren't sure why

In this episode:00:24 The quest to count the Amazon's insects07:31 The orcas that exploded a sunfishThe Guardian: Orcas seen ramming prey so hard it explodes may be playing gameTiktok: Orcas vs sunfishSubscribe to Nature Briefing, an unmissable daily round-up of science news, opi ...  Show more

Earthworks spotted in the Amazon hint at huge ancient civilization

In this episode:00:45 Ancient structures hidden beneath the Amazon’s canopyResearch article: Pärssinen et al.09:15 Research HighlightsNature: It’ll grow on you: live fungi formed into sustainable fashionPhysical Review Fluids: Gourmandie et al.11:48 Tiny fossils represent the ear ...  Show more

Recommended Episodes

The Global Vaccine Gap
Prognosis: Misconception

In a race to catch up with emerging coronavirus variants, wealthy countries are already benefiting from potent vaccines. While the U.S., Britain and European Union have given citizens about 24 million doses so far -- more than half of the shots administered globally -- vast numbe ...  Show more

The Evidence: To boost or not to boost?
Discovery

The divide between the Covid vaccine haves and have-nots has been described as “criminal”, with only 20% of people in low and middle income countries having had one dose, compared with 80% in higher income countries. Countries with high vaccination rates have been called on to gi ...  Show more

Agree to Disagree: Booster Shots
Open to Debate

The boosters are rolling out. In places likes the U.S., Britain, and Israel, authorities are providing additional Covid-19 vaccines with the goal of bolstering immune systems and shoring up their economies. Though vaccines such as Moderna and Pfizer-BioNTech have proven highly ef ...  Show more

Do We Need a Third Covid Shot?
The Daily

The rise of the Delta variant has prompted a thorny question: Do we need a booster dose of the vaccine for Covid-19? Vaccine makers think so, but regulators are yet to be convinced.

Principles are also at stake: Should richer countries be talking about administering extr ...

  Show more